Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jie Xia is active.

Publication


Featured researches published by Jie Xia.


Tetrahedron Letters | 2000

Use of 1,2-dichloro 4,5-dicyanoquinone (DDQ) for cleavage of the 2-naphthylmethyl (NAP) group

Jie Xia; S. A. Abbas; Robert D. Locke; Conrad F. Piskorz; James L. Alderfer; Khushi L. Matta

Abstract The 2-naphthylmethyl (NAP) group is a versatile group for protection of hydroxyl functions. It is stable to 4% TFA in CHCl 3 , hot 80% HOAc–H 2 O, SnCl 2 –AgOTf and HCl–EtOH, but it can readily be removed with DDQ in CH 2 Cl 2 .


Chemistry: A European Journal | 2001

The 2-naphthylmethyl (NAP) group in carbohydrate synthesis: first total synthesis of the GlyCAM-1 oligosaccharide structures.

Jie Xia; James L. Alderfer; Conrad F. Piskorz; Khushi L. Matta

Total syntheses of the GlyCAM-1 (glycosylation-dependent cell adhesion molecule-1) oligosaccharide structures: [alpha-NeuAc-(2 --> 3)-beta-Gal-(1 --> 4)-[alpha-Fuc-(1 --> 3)]-beta-(6-O-SO3Na)-GlcNAc-(1 --> 6)]-[alpha-NeuAc-(2 --> 3)-beta-Gal-(1 --> 3)]-alpha-GalNAc-OMe (1) and [alpha-NeuAc-(2 --> 3)-beta-Gal-(1 --> 4)-[alpha-Fuc-(1 --> 3)]-beta-GlcNAc-(1 --> 6)]-[alpha-NeuAc-(2 3)-beta-Gal-(1 --> 3)]-alpha-GalNAc-OMe (2) through a novel sialyl LewisX tetrasaccharide donor are described. Employing sequential glycosylation strategy, the starting trisaccharide was regio- and stereoselectively constructed through coupling of a disaccharide imidate with the monosaccharide acceptor phenyl-6-O-naphthylmethyl-2-deoxy-2-phthalimido-1-thio-beta-D-glucopyranoside with TMSOTf as a catalyst without affecting the SPh group. The novel sialyl Lewisx tetrasaccharide donor 3 was then obtained by alpha-L-fucosylation of trisaccharide acceptor with the 2,3,4-tri-O-benzyl-1-thio-beta-L-fucoside donor. The structure of the novel sialyl Lewisx tetrasaccharide was established by a combination of 2D DQF-COSY and 2D ROESY experiments. Target oligosaccharides 1 and 2 were eventually constructed through heptasaccharide which was obtained by regioselective assembly of advanced sialyl Lewisx tetrasaccharide donor 3 and a sialylated trisaccharide acceptor in a predictable and controlled manner. Finally, target heptasaccharides 1 and 2 were fully characterized by 2D DQF-COSY, 2D ROESY, HSQC, HMBC experiments and FAB mass spectroscopy.


Carbohydrate Research | 2000

Chemical synthesis of sulfated oligosaccharides with a β-d-Gal-(1→3)-[β-d-Gal-(1→4)-(α-l-Fuc-(1→3)-β-d-GlcNAc-(1→6)]-α-d-GalNAc sequence

Jie Xia; Thamarapu Srikrishnan; James L. Alderfer; Rakesh K. Jain; Conrad F. Piskorz; Khushi L. Matta

Abstract The syntheses of two sulfated pentasaccharides: β- d -Gal6SO 3 Na-(1→3)-[β- d -Gal-(1→4)-α- l -Fuc-(1→3)-β- d -GlcNAc-(1→6)]-α- d -GalNAc→OMe ( 1 ) and β- d -Gal6SO 3 Na-(1→3)-[β- d -Gal-(1→4)-α- l -Fuc-(1→3)-β- d -GlcNAc6SO 3 Na-(1→6)]-α- d -GalNAc→OMe ( 2 ) by using Lewis X trisaccharides 12 and 16 as glycosyl donors are described. Sulfated oligosaccharides 1 – 2 and intermediate compounds are fully characterized by 2D 1 H– 1 H DQF-COSY and 2D ROESY experiments.


Tetrahedron Letters | 2000

Total synthesis of a sialylated and sulfated oligosaccharide from O-linked glycoproteins

Jie Xia; Conrad F. Piskorz; James L. Alderfer; Robert D. Locke; Khushi L. Matta

Abstract The total synthesis of a sialylated and sulfated oligosaccharide 1 representative of a structure occurring in respiratory mucins has been accomplished. Our strategy depends upon the employment of 2-naphthymethyl (NAP) protection for hydroxyl functions. Choice of the well-defined sialyl donor 15 was made because of its enhanced reactivity over the parent compound 14 for glycosylation.


Chemistry: A European Journal | 2000

Total synthesis of sialylated and sulfated oligosaccharide chains from respiratory mucins.

Jie Xia; James L. Alderfer; Conrad F. Piskorz; Khushi L. Matta

The total syntheses of several complex oligosaccharide moieties that occur in the core structure of sulfated mucins are reported. A trisaccharide acceptor was obtained through regio- and stereoselective sialylation of methyl (6-O-pivaloyl-beta-D-galactopyanosyl)(1-->3)-4,6-O-benzylidene-2-a cetamido-2-deoxy-alpha-D-galactopyranoside with a novel sialyl donor. A tetrasaccharide, pentasaccharide, and hexasaccharide were constructed in predictable and controlled manner with high regio- and stereoselectivity after the successful preparation and employment of a disaccharide donor, trisaccharide donor, disaccharide acceptor, and trisaccharide acceptor building blocks. Finally, a mild oxidative cleaving method was adopted for the selective removal of 2-naphthylmethyl (NAP) in the presence of benzyl groups.


Journal of Proteome Research | 2012

Characterization of cancer associated mucin type O-glycans using the exchange sialylation properties of mammalian sialyltransferase ST3Gal-II

E. V. Chandrasekaran; Jun Xue; Jie Xia; Robert D. Locke; Shilpa A. Patil; Sriram Neelamegham; Khushi L. Matta

Our previous studies suggest that the α2,3sialylated T-antigen (NeuAcα2,3Galβ1,3GalNac-) and associated glycan structures are likely to be elevated during cancer. An easy and reliable strategy to label mucinous glycans that contain such carbohydrates can enable the identification of novel glycoproteins that are cancer associated. To this end, the present study demonstrates that the exchange sialylation property of mammalian ST3Gal-II can facilitate the labeling of mucin glycoproteins in cancer cells, tumor specimens, and glycoproteins in cancer sera. Results show that (i) the radiolabeled mucin glycoproteins of each of the cancer cell lines studied (T47D, MCF7, LS180, LNCaP, SKOV3, HL60, DU4475, and HepG2) is distinct either in terms of the specific glycans presented or their relative distribution. While some cell lines like T47D had only one single sialylated O-glycan, others like LS180 and DU4475 contained a complex mixture of mucinous carbohydrates. (ii) [14C]sialyl labeling of primary tumor cells identified a 25-35 kDa mucin glycoprotein unique to pancreatic tumor. Labeled glycoproteins for other cancers had higher molecular weight. (iii) Studies of [14C] sialylated human sera showed larger mucin glycopeptides and >2-fold larger mucin-type chains in human serum compared to [14C]sialyl labeled glycans of fetuin. Overall, the exchange sialylation property of ST3Gal-II provides an efficient avenue to identify mucinous proteins for applications in glycoproteomics and cancer research.


Carbohydrate Research | 2000

A convergent synthesis of trisaccharides with α-Neu5Ac-(2→3)-β-d-Gal-(1→4)-β-d-GlcNAc and α-Neu5Ac-(2→3)-β-d-Gal-(1→3)-α-d-GalNAc sequences

Jie Xia; James L. Alderfer; Conrad F. Piskorz; Robert D. Locke; Khushi L. Matta

Abstract The syntheses of three trisaccharides: α-Neu5Ac-(2→3)-β- d -Gal-(1→4)-β- d -GlcNAc→OMe, α-Neu5Ac-(2→3)-β- d -Gal6SO 3 Na-(1→4)-β- d -GlcNAc→OMe, and α-Neu5Ac-(2→3)-β- d -Gal-(1→3)-α- d -GalNAc→OBn were accomplished by using either methyl (phenyl 5-acetamido-4,7,8,9-tetra- O -acetyl-3,5-dideoxy-2-thio-β- d - glycero - d - galacto -2-nonulopyranoside)onate or methyl (phenyl N -acetyl-5-acetamido-4,7,8,9-tetra- O -acetyl-3,5-dideoxy-2-thio-β- d - glycero - d - galacto -2-nonulopyranoside)onate as the sialyl donor. The N , N -diacetylamino sialyl donor appears to be more reactive than its parent acetamido sugar when allowed to react with an disaccharide acceptor under the same glycosylation conditions. The trisaccharides, as well as the intermediate products, were fully characterized by 2D DQF 1 H– 1 H COSY and 2D ROESY spectroscopy.


Bioorganic & Medicinal Chemistry | 2002

A convergent synthesis of core 2 branched sialylated and sulfated oligosaccharides.

Jie Xia; James L. Alderfer; Thamarapu Srikrishnan; E. V. Chandrasekaran; Khushi L. Matta

A convergent pathway for the syntheses of core 2 oligosaccharide analogues 1 and 2, and a natural form sialylated and sulfated hexasaccharide 3 was developed. Construction of pentasaccharides 24, 27 and hexasaccharide 28 was achieved by complete regioselective glycosylation of the 6-OH in the acceptors 5, 7 and 8, respectively, owing to the much higher reactivity of the primary hydroxyl group over the secondary axial hydroxyl group in these structures. Stereoselective sialylation was accomplished using donor 10 with defined configuration established through X-ray crystallographic analysis. Target oligosaccharides 1-3 were then obtained by the systematic deprotection of intermediates 24, 27 and 29. With these target oligosaccharides 1-3 obtained, biological evaluations of these molecules as enzyme substrates was undertaken and selectin binding studies are planned.


Bioorganic & Medicinal Chemistry Letters | 2000

Chemical synthesis of a core 2 branched pentasaccharide containing a carboxylate group.

Jie Xia; James L. Alderfer; Khushi L. Matta

Design and synthesis of a carboxylate-containing pentasaccahride 1 with the Galbeta(1-4) (Fucalpha1-3)GlcNAcbeta(1-6)[3-[1-carboxymethyl]-Galbeta+ ++(1-3)]GalNAcalpha-OMe sequence, which is obtained through regioselective coupling of the 6-OH of a novel acceptor 9 with Lewis(x) donor 10 catalyzed by NIS-TfOH are described.


Bioorganic & Medicinal Chemistry Letters | 1999

An efficient synthesis of two monosulfated trisaccharides with the Galβ1,3GlcNAcβ1,3Galβ-O-Allyl backbone

Jie Xia; Conrad F. Piskorz; Robert D. Locke; E. V. Chandrasekaran; James L. Alderfer; Khushi L. Matta

Abstract The GlcNAcβ(1→3) Gal linked disaccharide 7 was synthesized as key building blocks for the construction of target monosulfated trisaccharides 1 and 2 using oxazoline 3 as glycosyl donor promoted by BF 3 ·Et 2 O

Collaboration


Dive into the Jie Xia's collaboration.

Top Co-Authors

Avatar

Khushi L. Matta

Roswell Park Cancer Institute

View shared research outputs
Top Co-Authors

Avatar

Conrad F. Piskorz

Roswell Park Cancer Institute

View shared research outputs
Top Co-Authors

Avatar

James L. Alderfer

Roswell Park Cancer Institute

View shared research outputs
Top Co-Authors

Avatar

Robert D. Locke

Roswell Park Cancer Institute

View shared research outputs
Top Co-Authors

Avatar

E. V. Chandrasekaran

Roswell Park Cancer Institute

View shared research outputs
Top Co-Authors

Avatar

Jun Xue

Roswell Park Cancer Institute

View shared research outputs
Top Co-Authors

Avatar

Sriram Neelamegham

State University of New York System

View shared research outputs
Top Co-Authors

Avatar

Thamarapu Srikrishnan

Roswell Park Cancer Institute

View shared research outputs
Top Co-Authors

Avatar

Ram Chawda

Roswell Park Cancer Institute

View shared research outputs
Top Co-Authors

Avatar

Shilpa A. Patil

State University of New York System

View shared research outputs
Researchain Logo
Decentralizing Knowledge